Maya Mehrara is a News Reporter at Newsweek based in London, U.K.. Her focus is reporting on international news. She has covered Ukraine, Russia, immigration issues, and the revolution in Iran.

Crypto.com secures regulatory approval as a Virtual Asset Service Provider in Argentina. - Helium has installed 100 new mobile hotspots in Mexico, increasing its total to 736. 39% of Latin ...

ORANGE PARK, Fla. — An Orange Park man contacted the Ask Anthony team after discovering a reporting error by VyStar Credit Union caused his credit score to drop by ...

CF Industries, the world's largest nitrogen fertilizer producer, boasts an economic moat with low-cost operations and superior logistics, ensuring consistent shareholder value. The company's ...

The Siegfried Line was a defensive perimeter around the western front of Germany, littered with pillboxes — bunkers — tank obstacles, and other defenses designed to slow the Allied advance.

Jeet Adani will join Shark Tank India as a mentor for the Devang Special week, focusing on businesses by differently-abled entrepreneurs. He will be joined by the visually impaired entrepreneur ...

Renergen may have no news out today but as of March 14, the company had transformed itself into a commercial producer of liquid helium. It noted that after facing challenges cooling large iso ...

removing underground storage tanks and repairing the winter work bridge recesses. During the 10-week-long shutdown, contractors completed the Poe Lock upstream stop log recess repairs. Kokosing ...

That is not something that would sit well with his competitive juices. For tank enthusiasts, this is a necessary evil of having a player like Maxey on the roster. If he returns there is no doubt ...

Jeet Adani, Director of Adani Airports, had earlier told Anupam Mittal that he would appear on Shark Tank India, but not as one of the ‘Sharks.’ Now, he has kept his promise and appeared as a mentor ...

Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene therapy and broader pipeline. Safety hadn’t been a major worry for ...